Benzinga's Top #PreMarket Gainers

shares climbed 13.87 percent to $4.35 in pre-market trading. Orexigen Therapeutics reported a Korean distributorship agreement with Kwang Dong Pharmaceutical Company and reported a Q2 loss of $22.5 million on revenue of $5.2 million.

shares rose 7.54 percent to $52.80 in pre-market trading after the company reported better-than-expected earnings for the second quarter and lifted its full-year earnings forecast.

gained 6.96 percent to $12.96 in pre-market trading after the company reported better-than-expected results for the second quarter.

shares rose 6.39 percent to $49.25 in pre-market trading as Bill Ackman disclosed a $5.5 billion stake in Mondelez.

shares climbed 6.05 percent to $42.25 in pre-market trading after the company reported stronger-than-expected results for its first fiscal quarter.